TG Therapeutics Inc.
Morrisville, NC
- UEI
- JKPZKD19WMD7
- CAGE
- 8TBE4
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 3020 Carrington Mill Blvd #475, Morrisville, NC 27560, USA
- Website
- tgtherapeutics.com
- Founded
- 2011
- Employees
- 251-1K
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract vehicles
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | Florham Park, NJ | 325412 Pharmaceutical Preparation Manufacturing |
| Summit SD LLC | Lee's Summit, MO | 424210 Drugs and Druggists' Sundries Merchant Wholesalers |
| Adma Biologics, Inc. | Ramsey, NJ | 325412 Pharmaceutical Preparation Manufacturing |
| Sanofi Genzyme | Cambridge, MA | 325412 Pharmaceutical Preparation Manufacturing |
| Fennec Pharmaceuticals, Inc. | Durham, NC | 325412 Pharmaceutical Preparation Manufacturing |
About the company
TG Therapeutics Inc. is a biopharmaceutical company that develops and commercializes treatments for blood cancers and autoimmune disorders. As a corporate entity registered in SAM.gov, TG Therapeutics provides hematology-focused pharmaceuticals and related medical supplies to U.S. government agencies, primarily the Department of Veterans Affairs (VA), through Federal Supply Schedule (FSS) contracts.
The company currently holds three active FSS contract IDVs awarded by VA's Veterans Integrated Service Network 12 to provide drugs, pharmaceuticals, and hematology products under GSA Schedule 65 IB, which covers these medical commodities. The most recent contract has a potential value of $250,000 through May 2028 and allows TG Therapeutics to fulfill orders for Schedule 65 IB products to treat veterans across VISN 12 facilities. Two prior IDVs enabled interim purchasing activity for pharmaceuticals, one with a potential value of $25,000 through May 2023 and another for $20 million through August 2026 under the parent GSA Pharmaceuticals and Drugs schedule. While specific task orders are unknown, based on the schedule descriptions and customer agency, the IDVs likely cover a range of medications commonly used in VA medical centers. As FSS contracts, all three utilized a multiple award approach without set-asides.
Quick answers
Is TG Therapeutics Inc. registered in SAM.gov?
Yes. TG Therapeutics Inc.'s SAM.gov registration is active through July 13, 2027.
What is TG Therapeutics Inc.'s CAGE code?
TG Therapeutics Inc.'s CAGE code is 8TBE4, and its Unique Entity ID (UEI) is JKPZKD19WMD7.
Which contract vehicles does TG Therapeutics Inc. hold?
TG Therapeutics Inc. holds a place on 1 federal contract vehicle: FSS-61-IB.
On GovTribe
See TG Therapeutics Inc.'s full federal record
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors